Speaking Faculty

Following is the preliminary speaking faculty for the 6th Annual Translational Microbiome Conference.

Please check back in the coming weeks for updates to this list or join our mailing list HERE

Mollie Roth, J.D.

Executive Director

The Microbiome Coalition (TMBC)

Shahram Lavasani, Ph.D.
Founder, CEO/CSO
Immune Biotech

Scott Jackson, Ph.D.
Group Leader, Complex Microbial Systems
NIST (National Institute of Standards & Technology)

Rachel Clemens, Ph.D.
Commercial Innovation Manager, Life Science Lead
ISS US National Lab, Center for Advancement in Science in Space

Lynne Elmore, Ph.D.
Director, Translational Cancer Research Program
American Cancer Society

Garth Ehrlich, Ph.D.
Professor of Microbiology & Immunology, Professor of Otolayngology - Head & Neck Surgery
Drexel University College of Medicine

Momo Vuyisch, Ph.D.
Chief Scientific Officer
Viome

Nancy Caralla
Foundiing President, Executive Director
C Diff Foundation

Rachel Teitelbaum, Ph.D.
Chief Executive Officer
Hervana

Sonia Timberlake, Ph.D.
Vice President of Research
Finch Therapeutics

Dae-Wook Kang, Ph.D.
Assistant Professor, Department of Civil & Environmental Engineering
University of Toledo

Sameer Sonkusale, Ph.D.
Prof. of Electrical & Computer Engineering, Prof. of Biomedical Engineering (adjunct), Director/Principal Investigator, Nano Lab
Tufts University

Amy Feehan, Ph.D.
Research Scientist
Ochsner Health System

Julius Goepp, MD
Chief Executive Officer
Scaled Microbiomics

Ze'ev Ronai, Ph.D.
Professor
Sanford Burnham Prebys Medical Discovery Institute

Wendy Garrett, Ph.D.
Prof. of Immunology & Infectious Diseases, Dept. of Genetics & Complex Diseases, Dept. of Medicine
Harvard Medical School

Steve Schnittger
VP Global Microbiology R&D
Estee Lauder

Lionel Breton, Ph.D., DSc
Scientific Director, L'Oreal Advanced Research
L'Oreal

Anandh Babu Pon Velayutham, Ph.D.
Associate Professor, Nutrition & Integrative Physiology
University of Utah

Sara Ferrando Martinez, Ph.D.
Research Scientist
AstraZeneca

A. Stewart Campbell, Ph.D.
Vice President, Early Stage Development
Axial Biotherapeutics

Gregg Silverman, MD
Professor of Medicine & Pathology
New York University School of Medicine

Henri Haiser, Ph.D.
Associate Scientific Director, GI Drug Discovery, Microbiome Sciences
Takeda

Mahmoud Ghannoum, Ph.D., EMBA
Professor, Department of Dematology
Case Western Reserve University and University Hospitals Cleveland Medical Center

Pamela Silver, Ph.D.
Elliot T. and Onie H. Adams Professor of Biochemistry and Systems Biology
Harvard Medical School

Our events give attendees a conference experience that encompasses learning, networking and professional growth. We strive to facilitate connections. At our events, attendees, speakers, sponsors and exhibitors have opportunities to network and then to utilize those connections to further their professional goals. At Arrowhead Publishers, our focus is on bringing life sciences industry professionals together to help move research forward. Learn more about us at www.arrowheadpublishers.com.

Arrowhead Publishers & Conferences
PO Box 96
7730 Laredo Drive, #96
Chanhassen, MN 55317
866-945-0263
enquiries@arrowheadpublishers.com

Continuing Medical Education Credits Now Available for this Event

Joint-Providership Accreditation and Designation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Office of Continuing Medical Education of the University of Virginia School of Medicine and Arrowhead Publishers. The Office of Continuing Medical Education of the University of Virginia School of Medicine is accredited by the ACCME to provide continuing medical education for physicians

The University of Virginia School of Medicine designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits.^TM Physicians should claim only the credit commensurate with the extent of their participation in the activity. (The number of credits offered for this event is subject to change dependent upon future additions/revisions to the agenda.)

The University of Virginia School of Medicine, as accredited provider, awards 4.25 hours of participation (consistent with the designated number of AMA PRA Category 1 Credit(s)TM ) to a participant who successfully completes this educational activity. The University of Virginia School of Medicine maintains a record of participation for six (6) years.